期刊文献+

过敏性哮喘患者穴位贴敷后诱发的接触性皮炎皮损处EOS浸润特点 被引量:6

EOS Infiltration Characteristics of Contact Dermatitis Induced by Acupoint Application in Allergic Asthma Patients
下载PDF
导出
摘要 目的:分析过敏性哮喘患者穴位贴敷后诱发的接触性皮炎皮损处嗜酸性粒细胞(eosinophils,EOS)浸润特点。方法:13例穴位贴敷治疗后诱发接触性皮炎并进行皮损处活检患者,按有无过敏性哮喘,分为过敏性哮喘组8例,非过敏性哮喘组5例。观察指标:(1)两组皮损处EOS聚集部位及数目的差异性;(2)两组真皮血管周围EOS病理结果分级的差异性。(3)两组表皮水泡液常规中EOS占总细胞数目百分比的差异性。结果:过敏性哮喘组真皮血管周围平均EOS数目(16.75±8.54)HP^(-1)明显高于无过敏史组(2.80±1.45)HP^(-1)。(1)过敏性哮喘组真皮血管周围EOS病理分级程度在Ⅲ、Ⅳ级(4例)重于非过敏性哮喘组(0例)。(2)过敏性哮喘组表皮水疱液EOS占总细胞百分比(45.3±17.1)%明显高于非过敏性哮喘组(12.7±4.4)%。结论:过敏性哮喘患者穴位贴敷后诱发的接触性皮炎皮损处EOS浸润程度增加。 Objective: To analyze the eosinophils( EOS) infiltration characteristics in patients with allergic asthma after acupoint application. Methods: 13 patients with contact dermatitis induced by acupoint application were divided into allergic asthma group( 8 patients) and non-allergic asthma group( 5 patients). The differences of the site and number of EOS at skin lesions,the EOS pathological grade differences and the percentage of EOS in the total number of cells in the two groups were observed. Results: The average number of EOS( 16. 75 ± 8. 54) · HP^-1 in allergic asthma group was significantly higher than that in non-allergic group( 2. 80 ± 1. 45) HP^-1. The degree of EOS pathology in the perihematoma of allergic asthma group was higher than that in non-allergic asthma group( 0 cases) in grade Ⅲ and Ⅳ( 4 cases). The percentage of total EOS in the epidermal blister fluid of the allergic asthma group was significantly higher than that in the non-allergic asthma group( 12. 7 ± 4. 4) %. Conclusion: The degree of EOS infiltration of contact dermatitis induced by acupoint application in allergic asthma patients increased.
出处 《中医学报》 CAS 2017年第11期2060-2063,共4页 Acta Chinese Medicine
基金 国家自然科学基金项目(81674065) 江苏省人力资源与社会保障厅"六大人才高峰"项目(2014-WSN-015)
关键词 过敏性哮喘 穴位贴敷 接触性皮炎 嗜酸性粒细胞 allergic asthma acupoint application contact dermatitis eosinophils
  • 相关文献

参考文献7

二级参考文献57

  • 1吴新贵,何源浩.背俞穴的主治作用及其机制[J].中国临床康复,2006,10(43):170-170. 被引量:94
  • 2王爱华.白细胞介素与支气管哮喘[J].上海免疫学杂志,1996,16(3):187-189. 被引量:18
  • 3钟南山.发展我国哮喘防治研究的特色[J].中华结核和呼吸杂志,1997,20:259-260.
  • 4中华人民共和国卫生部药政局.新药(西药)临床前研究指导原则汇编(药学、药理学、毒理学)[M].1993:200-203.
  • 5Szabo S J,Kim S T,Costa G L,et al.A novel transcrip-tion factor,T-bet,directs Th1lineage commitment[J].Cell,2000,100(6):655-669.
  • 6Finotto S,Neurath M F,Glickman J N,et a1.Develop-ment of spontaneous airway changes consistent withhuman asthma in mice lacking T-bet[J].Science,2002,295(5553):336-338.
  • 7Wegmann M.Th2cells as targets for therapeutic inter-vention in allergic bronchial asthma[J].Expert RevMol Diagn,2009,9(1):85-100.
  • 8Cousins D J,Lee T H,Staynov D Z.Cytokine coexpes-sion during human Thl/Th2cell differentiation:directevidence for coordinated expression of Th2cytokines[J].J Immunol,2002,169(5):2498-2506.
  • 9Yates A,Callard R,Stark J.Combining cytokine signal-ling with T-bet and GATA-3regulation in Thl andTh2 differentiation:a model for cellular decision-making[J].J Theoret Biol,2004,231(2):181-196.
  • 10Bousquet J, Van Cauwenberge P, Khaltaev N,et al. Allergic rhinitis and its impact on asthma.J Allergy Clin Immunol, 2001,108 (5 Suppl):147-334.

共引文献694

同被引文献109

引证文献6

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部